Elizabeth Robles

459 total citations
13 papers, 336 citations indexed

About

Elizabeth Robles is a scholar working on Molecular Biology, Obstetrics and Gynecology and Epidemiology. According to data from OpenAlex, Elizabeth Robles has authored 13 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Obstetrics and Gynecology and 4 papers in Epidemiology. Recurrent topics in Elizabeth Robles's work include Endometrial and Cervical Cancer Treatments (5 papers), Cervical Cancer and HPV Research (4 papers) and Histone Deacetylase Inhibitors Research (3 papers). Elizabeth Robles is often cited by papers focused on Endometrial and Cervical Cancer Treatments (5 papers), Cervical Cancer and HPV Research (4 papers) and Histone Deacetylase Inhibitors Research (3 papers). Elizabeth Robles collaborates with scholars based in Mexico, Colombia and United States. Elizabeth Robles's co-authors include Alfonso Dueñas‐González, Myrna Candelaria, Alma Chávez‐Blanco, Aurora González‐Fierro, Lucía Taja‐Chayeb, Alma Luísa Revilla Vázquez, Claudia Arce, Enrique Pérez‐Cárdenas, Catalina Trejo‐Becerril and Carlos Pérez‐Plasencia and has published in prestigious journals such as PLoS ONE, Annals of Oncology and BMC Cancer.

In The Last Decade

Elizabeth Robles

12 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth Robles Mexico 8 142 85 80 79 65 13 336
Kevin R. Brader United States 11 81 0.6× 157 1.8× 27 0.3× 139 1.8× 109 1.7× 14 370
Hagit Daum Israel 12 87 0.6× 25 0.3× 141 1.8× 83 1.1× 69 1.1× 39 420
Rupali Arora United Kingdom 12 117 0.8× 103 1.2× 42 0.5× 69 0.9× 47 0.7× 30 358
Angèle L.M. Oei Netherlands 7 75 0.5× 44 0.5× 72 0.9× 55 0.7× 99 1.5× 16 368
Maciej Stukan Poland 11 108 0.8× 76 0.9× 101 1.3× 98 1.2× 86 1.3× 42 376
Augusto F. Mesia United States 11 74 0.5× 166 2.0× 26 0.3× 54 0.7× 34 0.5× 17 327
Isabelle Marcillac France 5 108 0.8× 46 0.5× 55 0.7× 52 0.7× 42 0.6× 6 381
K Pavelka United States 7 89 0.6× 145 1.7× 69 0.9× 38 0.5× 29 0.4× 12 382
Luis Z. Blanco United States 11 69 0.5× 60 0.7× 37 0.5× 35 0.4× 165 2.5× 32 358
Masashi Nishiya Japan 9 97 0.7× 225 2.6× 22 0.3× 78 1.0× 54 0.8× 18 388

Countries citing papers authored by Elizabeth Robles

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Robles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Robles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Robles more than expected).

Fields of papers citing papers by Elizabeth Robles

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Robles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Robles. The network helps show where Elizabeth Robles may publish in the future.

Co-authorship network of co-authors of Elizabeth Robles

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Robles. A scholar is included among the top collaborators of Elizabeth Robles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Robles. Elizabeth Robles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Shah, Parth, et al.. (2025). Point-of-care glycemia testing in a safety-net dental care setting. The Journal of the American Dental Association. 156(4). 292–299.e1.
2.
Cetina, Lucely, et al.. (2007). The prognostic significance of leukocytosis in cervical cancer. International Journal of Gynecological Cancer. 17(2). 465–470. 25 indexed citations
3.
Candelaria, Myrna, Dolores Gallardo‐Rincón, Claudia Arce, et al.. (2007). A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors. BMC Cancer. 7(S1). 2 indexed citations
4.
Arce, Claudia, Carlos Pérez‐Plasencia, Aurora González‐Fierro, et al.. (2007). A proof-of-principle study of epigenetic therapy with hydralazine and magnesium valproate plus doxorubicin cyclophosphamide as neoadjuvant therapy for locally advanced breast cancer. BMC Cancer. 7(S1). 9 indexed citations
5.
Candelaria, Myrna, Lucely Cetina, Talía Wegman-Ostrosky, et al.. (2007). Epigenetic therapy with hydralazine and valproate associated to cisplatin chemoradiation in FIGO stage IIIB. A phase II study. BMC Cancer. 7(S1). 2 indexed citations
6.
Taja‐Chayeb, Lucía, Alma Chávez‐Blanco, Aurora González‐Fierro, et al.. (2006). Expression of platelet derived growth factor family members and the potential role of imatinib mesylate for cervical cancer. Cancer Cell International. 6(1). 22–22. 27 indexed citations
7.
Candelaria, Myrna, Lucely Cetina, C. López‐Graniel, et al.. (2006). Radiation-sparing managements for cervical cancer: a developing countries perspective. World Journal of Surgical Oncology. 4(1). 77–77. 13 indexed citations
8.
Arce, Claudia, Carlos Pérez‐Plasencia, Aurora González‐Fierro, et al.. (2006). A Proof-Of-Principle Study of Epigenetic Therapy Added to Neoadjuvant Doxorubicin Cyclophosphamide for Locally Advanced Breast Cancer. PLoS ONE. 1(1). e98–e98. 118 indexed citations
9.
Dueñas‐González, Alfonso, C. López‐Graniel, Ana Pilar González, et al.. (2001). A phase II study of gemcitabine and cisplatin combination as induction chemotherapy for untreated locally advanced cervical carcinoma. Annals of Oncology. 12(4). 541–547. 49 indexed citations
10.
López‐Graniel, C., et al.. (2001). Type III radical hysterectomy after induction chemotherapy for patients with locally advanced cervical carcinoma. International Journal of Gynecological Cancer. 11(3). 210–217. 15 indexed citations
11.
López‐Graniel, C., et al.. (2001). Type III radical hysterectomy after induction chemotherapy for patients with locally advanced cervical carcinoma. International Journal of Gynecological Cancer. 11(3). 210–217. 2 indexed citations
12.
Robles, Elizabeth, et al.. (1997). Facial growth and the need for orthognathic surgery after cleft palate repair: Literature review and report of 28 cases. Journal of Oral and Maxillofacial Surgery. 55(7). 694–697. 70 indexed citations
13.
Vilaclara, Gloria, et al.. (1988). Saprobic evaluation of Euglena viridis, E. agilis and E. proxima. Acta hydrochimica et hydrobiologica. 16(2). 187–188. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026